Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Percutaneous Coronary Intervention | 78 | 2023 | 440 | 8.260 |
Why?
|
Coronary Angiography | 38 | 2023 | 313 | 4.110 |
Why?
|
Myocardial Infarction | 49 | 2023 | 931 | 3.910 |
Why?
|
Registries | 70 | 2021 | 1773 | 3.560 |
Why?
|
Coronary Artery Disease | 27 | 2021 | 611 | 2.700 |
Why?
|
Cardiac Catheterization | 24 | 2022 | 535 | 2.290 |
Why?
|
Angioplasty, Balloon, Coronary | 25 | 2014 | 146 | 2.260 |
Why?
|
Transcatheter Aortic Valve Replacement | 8 | 2022 | 147 | 2.130 |
Why?
|
Aortic Valve Stenosis | 9 | 2022 | 250 | 1.900 |
Why?
|
Cardiology | 12 | 2022 | 260 | 1.680 |
Why?
|
Hemorrhage | 22 | 2022 | 616 | 1.570 |
Why?
|
Radial Artery | 17 | 2022 | 64 | 1.550 |
Why?
|
Cardiovascular Diseases | 13 | 2023 | 1724 | 1.340 |
Why?
|
Hospital Mortality | 29 | 2023 | 784 | 1.320 |
Why?
|
Drug-Eluting Stents | 13 | 2019 | 62 | 1.300 |
Why?
|
Femoral Artery | 14 | 2022 | 168 | 1.120 |
Why?
|
Aged | 117 | 2021 | 19298 | 1.110 |
Why?
|
Platelet Aggregation Inhibitors | 14 | 2019 | 400 | 1.090 |
Why?
|
Ultrasonography, Interventional | 6 | 2015 | 132 | 1.080 |
Why?
|
Acute Coronary Syndrome | 10 | 2022 | 253 | 1.050 |
Why?
|
Heart Valve Prosthesis | 4 | 2021 | 120 | 1.040 |
Why?
|
United States | 82 | 2023 | 12340 | 1.010 |
Why?
|
Ticlopidine | 7 | 2016 | 55 | 0.980 |
Why?
|
Treatment Outcome | 72 | 2023 | 9165 | 0.960 |
Why?
|
Postoperative Complications | 12 | 2019 | 2167 | 0.950 |
Why?
|
Coronary Artery Bypass | 11 | 2021 | 195 | 0.950 |
Why?
|
Pacemaker, Artificial | 18 | 2018 | 104 | 0.940 |
Why?
|
Contrast Media | 7 | 2023 | 366 | 0.940 |
Why?
|
Influenza Pandemic, 1918-1919 | 1 | 2023 | 1 | 0.900 |
Why?
|
Catheterization, Peripheral | 7 | 2022 | 104 | 0.850 |
Why?
|
Coronary Stenosis | 7 | 2014 | 39 | 0.840 |
Why?
|
Humans | 195 | 2023 | 115899 | 0.810 |
Why?
|
Purinergic P2Y Receptor Antagonists | 7 | 2019 | 63 | 0.810 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2023 | 139 | 0.790 |
Why?
|
Shock, Cardiogenic | 10 | 2023 | 52 | 0.780 |
Why?
|
Electrocardiography | 21 | 2020 | 554 | 0.760 |
Why?
|
Stents | 14 | 2016 | 477 | 0.760 |
Why?
|
Middle Aged | 95 | 2021 | 27082 | 0.750 |
Why?
|
Risk Factors | 45 | 2023 | 8714 | 0.750 |
Why?
|
Imaging, Three-Dimensional | 12 | 2016 | 496 | 0.720 |
Why?
|
Hospitals | 10 | 2022 | 582 | 0.700 |
Why?
|
Coronary Vessels | 10 | 2019 | 230 | 0.700 |
Why?
|
Male | 128 | 2022 | 56125 | 0.690 |
Why?
|
Female | 128 | 2022 | 60080 | 0.680 |
Why?
|
Radiography, Interventional | 8 | 2019 | 111 | 0.680 |
Why?
|
Aortic Valve | 7 | 2022 | 338 | 0.680 |
Why?
|
Computer Simulation | 6 | 2014 | 887 | 0.670 |
Why?
|
Time Factors | 35 | 2021 | 6186 | 0.670 |
Why?
|
Acute Kidney Injury | 4 | 2023 | 647 | 0.650 |
Why?
|
Coronary Restenosis | 3 | 2013 | 18 | 0.620 |
Why?
|
Risk Assessment | 24 | 2021 | 3004 | 0.610 |
Why?
|
ST Elevation Myocardial Infarction | 4 | 2023 | 51 | 0.590 |
Why?
|
Practice Patterns, Physicians' | 10 | 2019 | 1177 | 0.570 |
Why?
|
Echocardiography, Three-Dimensional | 4 | 2019 | 48 | 0.550 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2013 | 10 | 0.550 |
Why?
|
Follow-Up Studies | 29 | 2021 | 4446 | 0.550 |
Why?
|
Myocardial Ischemia | 6 | 2013 | 238 | 0.550 |
Why?
|
Hospitals, High-Volume | 6 | 2021 | 39 | 0.540 |
Why?
|
Graft Occlusion, Vascular | 4 | 2019 | 35 | 0.530 |
Why?
|
Medicare | 12 | 2021 | 666 | 0.510 |
Why?
|
Hospitals, Low-Volume | 5 | 2021 | 22 | 0.510 |
Why?
|
Survival Rate | 12 | 2021 | 1653 | 0.500 |
Why?
|
Allografts | 1 | 2015 | 127 | 0.500 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 9 | 2019 | 108 | 0.490 |
Why?
|
Models, Cardiovascular | 2 | 2013 | 172 | 0.490 |
Why?
|
Prasugrel Hydrochloride | 5 | 2016 | 18 | 0.480 |
Why?
|
Fluoroscopy | 7 | 2021 | 142 | 0.480 |
Why?
|
Aged, 80 and over | 36 | 2021 | 6438 | 0.480 |
Why?
|
Cardiac Pacing, Artificial | 12 | 2007 | 79 | 0.480 |
Why?
|
Intra-Aortic Balloon Pumping | 4 | 2021 | 15 | 0.480 |
Why?
|
Vascular Diseases | 2 | 2015 | 230 | 0.450 |
Why?
|
Heart Arrest | 4 | 2021 | 289 | 0.450 |
Why?
|
Coronary Disease | 8 | 2012 | 349 | 0.440 |
Why?
|
Heart Defects, Congenital | 4 | 2021 | 682 | 0.440 |
Why?
|
Postoperative Hemorrhage | 4 | 2016 | 78 | 0.440 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 64 | 0.430 |
Why?
|
Quality Indicators, Health Care | 5 | 2021 | 285 | 0.430 |
Why?
|
Coronary Thrombosis | 2 | 2012 | 25 | 0.420 |
Why?
|
Heart-Assist Devices | 4 | 2023 | 486 | 0.420 |
Why?
|
Retrospective Studies | 35 | 2023 | 12616 | 0.400 |
Why?
|
Teaching | 1 | 2013 | 226 | 0.380 |
Why?
|
Heart Failure | 2 | 2023 | 1959 | 0.380 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2021 | 172 | 0.380 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 343 | 0.370 |
Why?
|
Coronavirus Infections | 3 | 2020 | 335 | 0.370 |
Why?
|
Clinical Competence | 7 | 2017 | 918 | 0.370 |
Why?
|
Decision Support Techniques | 5 | 2020 | 352 | 0.370 |
Why?
|
Coronary Aneurysm | 1 | 2010 | 11 | 0.360 |
Why?
|
Anticoagulants | 6 | 2015 | 545 | 0.360 |
Why?
|
Heart Block | 8 | 2018 | 37 | 0.360 |
Why?
|
Echocardiography, Transesophageal | 4 | 2021 | 90 | 0.360 |
Why?
|
Arrhythmias, Cardiac | 7 | 2023 | 275 | 0.360 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 1403 | 0.350 |
Why?
|
Hemostatic Techniques | 3 | 2020 | 40 | 0.350 |
Why?
|
Endovascular Procedures | 3 | 2020 | 276 | 0.340 |
Why?
|
Education, Medical, Graduate | 1 | 2013 | 374 | 0.340 |
Why?
|
Heart Transplantation | 1 | 2015 | 672 | 0.340 |
Why?
|
Patient Readmission | 6 | 2022 | 607 | 0.330 |
Why?
|
Peptide Fragments | 6 | 2020 | 675 | 0.330 |
Why?
|
Predictive Value of Tests | 16 | 2020 | 1817 | 0.330 |
Why?
|
Image Enhancement | 2 | 2010 | 175 | 0.330 |
Why?
|
Veterans | 2 | 2019 | 1232 | 0.330 |
Why?
|
Radiation Dosage | 7 | 2016 | 141 | 0.330 |
Why?
|
Hirudins | 6 | 2020 | 46 | 0.310 |
Why?
|
Cardiology Service, Hospital | 2 | 2020 | 28 | 0.310 |
Why?
|
Patient Simulation | 1 | 2008 | 30 | 0.300 |
Why?
|
Quality Improvement | 5 | 2019 | 956 | 0.300 |
Why?
|
Myocardial Revascularization | 6 | 2016 | 67 | 0.300 |
Why?
|
Incidence | 12 | 2020 | 2333 | 0.290 |
Why?
|
Prospective Studies | 20 | 2023 | 6266 | 0.290 |
Why?
|
Length of Stay | 6 | 2019 | 963 | 0.290 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2021 | 230 | 0.280 |
Why?
|
Workload | 2 | 2019 | 132 | 0.280 |
Why?
|
Defibrillators, Implantable | 3 | 2022 | 279 | 0.280 |
Why?
|
Device Removal | 3 | 2005 | 128 | 0.280 |
Why?
|
Societies, Medical | 4 | 2020 | 690 | 0.280 |
Why?
|
Pandemics | 4 | 2023 | 1333 | 0.270 |
Why?
|
Propensity Score | 7 | 2020 | 225 | 0.270 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2019 | 53 | 0.260 |
Why?
|
Antithrombins | 4 | 2020 | 48 | 0.260 |
Why?
|
Drug Substitution | 2 | 2016 | 46 | 0.260 |
Why?
|
Advisory Committees | 2 | 2020 | 208 | 0.260 |
Why?
|
Patient Discharge | 5 | 2022 | 770 | 0.260 |
Why?
|
Comorbidity | 8 | 2019 | 1476 | 0.250 |
Why?
|
American Heart Association | 3 | 2016 | 266 | 0.250 |
Why?
|
Consensus | 4 | 2020 | 533 | 0.250 |
Why?
|
Odds Ratio | 10 | 2017 | 970 | 0.250 |
Why?
|
Education, Medical | 1 | 2008 | 224 | 0.240 |
Why?
|
Heart Septum | 2 | 2015 | 27 | 0.240 |
Why?
|
Peripheral Vascular Diseases | 2 | 2019 | 98 | 0.240 |
Why?
|
Healthcare Disparities | 3 | 2020 | 487 | 0.240 |
Why?
|
Prognosis | 7 | 2020 | 3342 | 0.240 |
Why?
|
Thrombolytic Therapy | 3 | 2020 | 118 | 0.240 |
Why?
|
Time-to-Treatment | 3 | 2014 | 147 | 0.240 |
Why?
|
Comparative Effectiveness Research | 6 | 2016 | 130 | 0.240 |
Why?
|
Aspirin | 3 | 2015 | 327 | 0.240 |
Why?
|
Angiography | 4 | 2021 | 177 | 0.230 |
Why?
|
Sex Factors | 6 | 2019 | 1743 | 0.230 |
Why?
|
Cardiologists | 2 | 2021 | 41 | 0.230 |
Why?
|
Kidney Diseases | 2 | 2023 | 355 | 0.230 |
Why?
|
Internship and Residency | 1 | 2013 | 949 | 0.230 |
Why?
|
Learning Curve | 2 | 2015 | 66 | 0.230 |
Why?
|
Certification | 2 | 2015 | 90 | 0.230 |
Why?
|
Heart Diseases | 3 | 2019 | 337 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2015 | 121 | 0.220 |
Why?
|
Research Design | 3 | 2022 | 947 | 0.220 |
Why?
|
Intraoperative Care | 2 | 2013 | 36 | 0.220 |
Why?
|
Myocardial Reperfusion | 2 | 2013 | 51 | 0.220 |
Why?
|
Age Factors | 9 | 2020 | 2915 | 0.210 |
Why?
|
Betacoronavirus | 3 | 2020 | 253 | 0.210 |
Why?
|
Cineangiography | 5 | 2009 | 16 | 0.210 |
Why?
|
Heart Injuries | 1 | 2023 | 37 | 0.210 |
Why?
|
Severity of Illness Index | 12 | 2020 | 2598 | 0.210 |
Why?
|
Enoxaparin | 2 | 2015 | 52 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2019 | 488 | 0.200 |
Why?
|
Multimodal Imaging | 2 | 2019 | 98 | 0.200 |
Why?
|
Breast Neoplasms | 1 | 2013 | 1870 | 0.200 |
Why?
|
History, 20th Century | 1 | 2023 | 276 | 0.200 |
Why?
|
Heart Ventricles | 6 | 2018 | 712 | 0.200 |
Why?
|
Guideline Adherence | 3 | 2015 | 495 | 0.200 |
Why?
|
Forecasting | 2 | 2022 | 332 | 0.200 |
Why?
|
Physicians | 3 | 2015 | 774 | 0.200 |
Why?
|
Technology Transfer | 1 | 2021 | 13 | 0.200 |
Why?
|
Stroke | 6 | 2019 | 1014 | 0.200 |
Why?
|
Longitudinal Studies | 10 | 2019 | 2437 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2021 | 243 | 0.190 |
Why?
|
Retreatment | 3 | 2019 | 70 | 0.180 |
Why?
|
Proportional Hazards Models | 8 | 2016 | 1088 | 0.180 |
Why?
|
Ischemia | 3 | 2009 | 363 | 0.180 |
Why?
|
Surgicenters | 1 | 2020 | 6 | 0.180 |
Why?
|
Saphenous Vein | 3 | 2015 | 31 | 0.180 |
Why?
|
Thrombosis | 3 | 2016 | 302 | 0.180 |
Why?
|
Manuals as Topic | 1 | 2020 | 13 | 0.180 |
Why?
|
Ethanol | 2 | 2015 | 549 | 0.180 |
Why?
|
Septal Occluder Device | 2 | 2018 | 47 | 0.180 |
Why?
|
Databases, Factual | 5 | 2020 | 1149 | 0.180 |
Why?
|
Assisted Circulation | 2 | 2021 | 24 | 0.170 |
Why?
|
Rural Health Services | 1 | 2020 | 93 | 0.170 |
Why?
|
Reproducibility of Results | 8 | 2021 | 2814 | 0.170 |
Why?
|
Chi-Square Distribution | 6 | 2017 | 502 | 0.170 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2020 | 78 | 0.170 |
Why?
|
Logistic Models | 8 | 2017 | 1865 | 0.170 |
Why?
|
Atrial Fibrillation | 3 | 2007 | 314 | 0.170 |
Why?
|
Absorbable Implants | 1 | 2019 | 35 | 0.170 |
Why?
|
Popliteal Artery | 2 | 2009 | 59 | 0.160 |
Why?
|
Angina Pectoris | 1 | 2019 | 62 | 0.160 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2019 | 37 | 0.160 |
Why?
|
Electrodes, Implanted | 5 | 1999 | 93 | 0.160 |
Why?
|
Atrioventricular Block | 1 | 2019 | 35 | 0.160 |
Why?
|
Infection Control | 1 | 2020 | 137 | 0.160 |
Why?
|
Medicaid | 2 | 2013 | 411 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2015 | 694 | 0.160 |
Why?
|
Models, Anatomic | 2 | 2009 | 92 | 0.160 |
Why?
|
Cohort Studies | 11 | 2023 | 4961 | 0.160 |
Why?
|
Vascular System Injuries | 1 | 2019 | 65 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2016 | 578 | 0.160 |
Why?
|
Health Care Costs | 2 | 2019 | 386 | 0.160 |
Why?
|
Recombinant Proteins | 8 | 2020 | 1243 | 0.150 |
Why?
|
Myocardium | 1 | 2023 | 929 | 0.150 |
Why?
|
Subacute Care | 1 | 2018 | 70 | 0.150 |
Why?
|
Rotation | 5 | 2011 | 113 | 0.150 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 126 | 0.150 |
Why?
|
Vascular Surgical Procedures | 3 | 2009 | 262 | 0.150 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 180 | 0.140 |
Why?
|
Purinergic P1 Receptor Antagonists | 1 | 2016 | 7 | 0.140 |
Why?
|
Patient Reported Outcome Measures | 1 | 2019 | 251 | 0.140 |
Why?
|
Leg | 2 | 2009 | 227 | 0.140 |
Why?
|
Angioplasty, Balloon | 2 | 2007 | 90 | 0.140 |
Why?
|
Multidetector Computed Tomography | 1 | 2016 | 26 | 0.140 |
Why?
|
Tachycardia, Ventricular | 1 | 2018 | 145 | 0.130 |
Why?
|
Aortography | 1 | 2016 | 51 | 0.130 |
Why?
|
Equipment Design | 7 | 2014 | 516 | 0.130 |
Why?
|
Long Term Adverse Effects | 1 | 2015 | 10 | 0.130 |
Why?
|
Heart Valve Diseases | 2 | 2015 | 117 | 0.130 |
Why?
|
Syncope | 1 | 2016 | 36 | 0.130 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 961 | 0.130 |
Why?
|
Blood Loss, Surgical | 2 | 2013 | 86 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2016 | 96 | 0.130 |
Why?
|
Aortic Valve Insufficiency | 1 | 2015 | 43 | 0.130 |
Why?
|
Metals | 1 | 2016 | 110 | 0.130 |
Why?
|
Elective Surgical Procedures | 2 | 2013 | 155 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 43 | 0.130 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2015 | 2 | 0.130 |
Why?
|
Injections | 3 | 2014 | 163 | 0.130 |
Why?
|
Education, Medical, Continuing | 2 | 2013 | 119 | 0.130 |
Why?
|
Vascular Grafting | 1 | 2015 | 12 | 0.130 |
Why?
|
Platelet Activation | 1 | 2015 | 68 | 0.130 |
Why?
|
Punctures | 3 | 2020 | 37 | 0.120 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 107 | 0.120 |
Why?
|
Embolic Protection Devices | 1 | 2015 | 11 | 0.120 |
Why?
|
Ablation Techniques | 1 | 2015 | 29 | 0.120 |
Why?
|
Catheter Ablation | 1 | 2018 | 280 | 0.120 |
Why?
|
Delivery of Health Care | 2 | 2023 | 847 | 0.120 |
Why?
|
Radiation Injuries | 1 | 2015 | 128 | 0.120 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2015 | 51 | 0.120 |
Why?
|
Prosthesis Design | 2 | 2013 | 290 | 0.120 |
Why?
|
Health Services Accessibility | 1 | 2020 | 771 | 0.120 |
Why?
|
Thrombectomy | 2 | 2012 | 53 | 0.120 |
Why?
|
Warfarin | 1 | 2015 | 136 | 0.120 |
Why?
|
Pharmacogenetics | 1 | 2015 | 153 | 0.120 |
Why?
|
Therapy, Computer-Assisted | 1 | 2014 | 58 | 0.120 |
Why?
|
Quality Assurance, Health Care | 2 | 2020 | 319 | 0.120 |
Why?
|
Creatine Kinase, MB Form | 1 | 2013 | 4 | 0.120 |
Why?
|
Renal Dialysis | 3 | 2014 | 371 | 0.110 |
Why?
|
Academies and Institutes | 1 | 2013 | 44 | 0.110 |
Why?
|
Withholding Treatment | 1 | 2014 | 69 | 0.110 |
Why?
|
Radiation | 1 | 2013 | 25 | 0.110 |
Why?
|
Adult | 17 | 2015 | 30816 | 0.110 |
Why?
|
Patient Selection | 5 | 2019 | 656 | 0.110 |
Why?
|
Hemostasis, Surgical | 1 | 2013 | 21 | 0.110 |
Why?
|
Heparin | 2 | 2015 | 226 | 0.110 |
Why?
|
Cardiac Volume | 2 | 2003 | 12 | 0.110 |
Why?
|
Fibrinolytic Agents | 2 | 2009 | 233 | 0.110 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 128 | 0.110 |
Why?
|
Coronary Occlusion | 1 | 2012 | 18 | 0.110 |
Why?
|
Wound Closure Techniques | 1 | 2012 | 9 | 0.100 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2012 | 15 | 0.100 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2015 | 246 | 0.100 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 1358 | 0.100 |
Why?
|
Medical Audit | 1 | 2012 | 76 | 0.100 |
Why?
|
Blood Platelets | 1 | 2015 | 350 | 0.100 |
Why?
|
Ambulatory Care | 1 | 2016 | 480 | 0.100 |
Why?
|
Embolism | 1 | 2012 | 43 | 0.100 |
Why?
|
Quality of Life | 4 | 2019 | 2392 | 0.100 |
Why?
|
Angina, Unstable | 1 | 2012 | 72 | 0.100 |
Why?
|
Creatinine | 3 | 2023 | 431 | 0.100 |
Why?
|
Aneurysm, False | 1 | 2012 | 46 | 0.100 |
Why?
|
Medication Adherence | 1 | 2016 | 536 | 0.100 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2012 | 69 | 0.100 |
Why?
|
Triiodobenzoic Acids | 2 | 2011 | 13 | 0.100 |
Why?
|
Insurance Claim Review | 1 | 2012 | 67 | 0.100 |
Why?
|
United States Department of Veterans Affairs | 2 | 2019 | 556 | 0.100 |
Why?
|
Polyethylene Terephthalates | 1 | 1991 | 15 | 0.090 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 296 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2014 | 468 | 0.090 |
Why?
|
Manikins | 1 | 2010 | 25 | 0.090 |
Why?
|
Cardiovascular Agents | 4 | 2016 | 125 | 0.090 |
Why?
|
Angioplasty | 1 | 2010 | 40 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 4 | 2014 | 819 | 0.090 |
Why?
|
Movement | 2 | 2009 | 246 | 0.090 |
Why?
|
Glomerular Filtration Rate | 3 | 2023 | 605 | 0.090 |
Why?
|
Recurrence | 4 | 2016 | 949 | 0.090 |
Why?
|
Prevalence | 5 | 2019 | 2271 | 0.090 |
Why?
|
Coronary Vessel Anomalies | 1 | 2009 | 31 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 1842 | 0.080 |
Why?
|
Multivariate Analysis | 4 | 2014 | 1444 | 0.080 |
Why?
|
Cause of Death | 3 | 2020 | 369 | 0.080 |
Why?
|
Prosthesis Failure | 1 | 2010 | 116 | 0.080 |
Why?
|
Equipment Failure | 2 | 2005 | 109 | 0.080 |
Why?
|
Algorithms | 6 | 2020 | 1493 | 0.080 |
Why?
|
Drug Administration Schedule | 3 | 2019 | 724 | 0.080 |
Why?
|
Carotid Stenosis | 1 | 2009 | 78 | 0.080 |
Why?
|
Vascular Closure Devices | 2 | 2020 | 6 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2010 | 181 | 0.080 |
Why?
|
Heart Atria | 6 | 1990 | 109 | 0.080 |
Why?
|
Preoperative Period | 2 | 2021 | 103 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2015 | 830 | 0.080 |
Why?
|
Hyperbaric Oxygenation | 2 | 1998 | 37 | 0.080 |
Why?
|
Aftercare | 2 | 2022 | 187 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 2 | 2009 | 209 | 0.070 |
Why?
|
Cardiac Output, Low | 1 | 2007 | 64 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 2408 | 0.070 |
Why?
|
Clinical Decision-Making | 2 | 2020 | 275 | 0.070 |
Why?
|
Biomarkers | 4 | 2023 | 3473 | 0.070 |
Why?
|
Extremities | 1 | 2007 | 113 | 0.070 |
Why?
|
Hemodynamics | 3 | 2020 | 970 | 0.070 |
Why?
|
Mortality | 3 | 2016 | 293 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 4449 | 0.070 |
Why?
|
Radiographic Image Enhancement | 2 | 2006 | 59 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 2 | 1998 | 228 | 0.070 |
Why?
|
Lower Extremity | 1 | 2009 | 338 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 1216 | 0.070 |
Why?
|
Treatment Refusal | 1 | 2006 | 84 | 0.060 |
Why?
|
Systole | 2 | 1983 | 168 | 0.060 |
Why?
|
Blood Vessel Prosthesis | 1 | 2006 | 117 | 0.060 |
Why?
|
Sirolimus | 1 | 2006 | 192 | 0.060 |
Why?
|
Patient Safety | 2 | 2020 | 276 | 0.060 |
Why?
|
Vascular Patency | 3 | 2012 | 98 | 0.060 |
Why?
|
Intraoperative Complications | 2 | 2018 | 126 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 906 | 0.060 |
Why?
|
Prosthesis Implantation | 1 | 2006 | 139 | 0.060 |
Why?
|
Equipment Safety | 1 | 2004 | 40 | 0.060 |
Why?
|
Stroke Volume | 4 | 2015 | 508 | 0.060 |
Why?
|
Peptides | 1 | 2009 | 862 | 0.060 |
Why?
|
Reoperation | 2 | 2021 | 526 | 0.060 |
Why?
|
Electric Countershock | 1 | 2005 | 101 | 0.060 |
Why?
|
Prosthesis-Related Infections | 1 | 2005 | 70 | 0.060 |
Why?
|
Adenosine | 2 | 2016 | 204 | 0.060 |
Why?
|
Risk | 3 | 2012 | 830 | 0.060 |
Why?
|
United States Food and Drug Administration | 2 | 2016 | 173 | 0.060 |
Why?
|
Survival Analysis | 3 | 2013 | 1221 | 0.060 |
Why?
|
Patient Preference | 2 | 2016 | 171 | 0.060 |
Why?
|
Catheters | 1 | 2023 | 64 | 0.050 |
Why?
|
Troponin | 1 | 2023 | 45 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 1728 | 0.050 |
Why?
|
Pyridines | 1 | 2006 | 425 | 0.050 |
Why?
|
Kidney | 2 | 2023 | 1208 | 0.050 |
Why?
|
Mass Screening | 1 | 2009 | 1023 | 0.050 |
Why?
|
Curriculum | 1 | 2008 | 853 | 0.050 |
Why?
|
Risk Adjustment | 2 | 2013 | 79 | 0.050 |
Why?
|
Diagnosis-Related Groups | 1 | 2021 | 29 | 0.050 |
Why?
|
Physical Exertion | 1 | 1982 | 208 | 0.050 |
Why?
|
Endocardium | 2 | 1990 | 31 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 1982 | 316 | 0.050 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 200 | 0.050 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 78 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 102 | 0.050 |
Why?
|
Florida | 1 | 2020 | 73 | 0.050 |
Why?
|
Pressure | 2 | 2012 | 218 | 0.050 |
Why?
|
Heart Rate | 4 | 2011 | 698 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2021 | 118 | 0.040 |
Why?
|
Matched-Pair Analysis | 1 | 2020 | 35 | 0.040 |
Why?
|
Population Density | 1 | 2020 | 95 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 180 | 0.040 |
Why?
|
Models, Statistical | 2 | 2014 | 616 | 0.040 |
Why?
|
Tachycardia, Supraventricular | 2 | 1990 | 40 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 1128 | 0.040 |
Why?
|
Travel | 1 | 2020 | 121 | 0.040 |
Why?
|
Device Approval | 1 | 2019 | 21 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 363 | 0.040 |
Why?
|
Observer Variation | 2 | 2011 | 299 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2020 | 131 | 0.040 |
Why?
|
Anatomic Landmarks | 1 | 2019 | 24 | 0.040 |
Why?
|
Colorado | 3 | 2019 | 4122 | 0.040 |
Why?
|
Hospitals, University | 1 | 2019 | 172 | 0.040 |
Why?
|
Patient-Specific Modeling | 1 | 2019 | 37 | 0.040 |
Why?
|
Hospitals, Urban | 1 | 2019 | 129 | 0.040 |
Why?
|
Writing | 1 | 2020 | 85 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 545 | 0.040 |
Why?
|
Residence Characteristics | 1 | 2020 | 278 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 1997 | 7 | 0.040 |
Why?
|
Social Media | 1 | 2020 | 135 | 0.040 |
Why?
|
Exercise Test | 3 | 2014 | 541 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1032 | 0.040 |
Why?
|
Data Collection | 1 | 2020 | 636 | 0.040 |
Why?
|
Adenosine Diphosphate | 1 | 2016 | 81 | 0.030 |
Why?
|
Disease Management | 1 | 2020 | 562 | 0.030 |
Why?
|
Automation | 1 | 2016 | 73 | 0.030 |
Why?
|
Radiologic Health | 1 | 2015 | 5 | 0.030 |
Why?
|
Drug Costs | 1 | 2016 | 91 | 0.030 |
Why?
|
Radiation Exposure | 1 | 2016 | 41 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2016 | 102 | 0.030 |
Why?
|
Technology Assessment, Biomedical | 1 | 2015 | 29 | 0.030 |
Why?
|
Netherlands | 1 | 2015 | 65 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2020 | 686 | 0.030 |
Why?
|
Platelet Function Tests | 1 | 2015 | 24 | 0.030 |
Why?
|
Health Expenditures | 1 | 2016 | 174 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2007 | 256 | 0.030 |
Why?
|
Early Termination of Clinical Trials | 1 | 2014 | 14 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1994 | 28 | 0.030 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2015 | 38 | 0.030 |
Why?
|
Thrombelastography | 1 | 2015 | 179 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 945 | 0.030 |
Why?
|
Patient Admission | 1 | 2016 | 175 | 0.030 |
Why?
|
Echocardiography, Stress | 1 | 2014 | 19 | 0.030 |
Why?
|
Hospital Costs | 1 | 2015 | 106 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2015 | 233 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2014 | 36 | 0.030 |
Why?
|
Angina, Stable | 1 | 2014 | 17 | 0.030 |
Why?
|
Virginia | 1 | 2013 | 53 | 0.030 |
Why?
|
Blood Pressure | 3 | 2011 | 1536 | 0.030 |
Why?
|
Echocardiography | 2 | 2014 | 566 | 0.030 |
Why?
|
Atrial Function | 2 | 1990 | 11 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 2013 | 170 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2014 | 77 | 0.030 |
Why?
|
Professional Competence | 1 | 2014 | 85 | 0.030 |
Why?
|
Solvents | 1 | 2014 | 109 | 0.030 |
Why?
|
Administration, Oral | 1 | 2015 | 731 | 0.030 |
Why?
|
Foundations | 1 | 2013 | 22 | 0.030 |
Why?
|
Canada | 1 | 2014 | 337 | 0.030 |
Why?
|
Cladribine | 1 | 1993 | 2 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 219 | 0.030 |
Why?
|
Sinoatrial Node | 2 | 1990 | 27 | 0.030 |
Why?
|
Telemetry | 2 | 1989 | 35 | 0.030 |
Why?
|
Research Report | 1 | 2013 | 76 | 0.030 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1993 | 72 | 0.030 |
Why?
|
Observation | 1 | 2012 | 50 | 0.030 |
Why?
|
Software | 1 | 2016 | 531 | 0.030 |
Why?
|
Linear Models | 1 | 2014 | 778 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2012 | 310 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 1993 | 93 | 0.020 |
Why?
|
Posture | 2 | 2009 | 150 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 299 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 1868 | 0.020 |
Why?
|
Pectoralis Muscles | 1 | 1991 | 14 | 0.020 |
Why?
|
Esthetics | 1 | 1991 | 37 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2007 | 750 | 0.020 |
Why?
|
Consumer Behavior | 1 | 1991 | 65 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 341 | 0.020 |
Why?
|
Leukemia | 1 | 1993 | 207 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 1991 | 66 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 338 | 0.020 |
Why?
|
Automation, Laboratory | 1 | 2010 | 7 | 0.020 |
Why?
|
X-Rays | 1 | 2010 | 31 | 0.020 |
Why?
|
Tachycardia, Paroxysmal | 1 | 1989 | 7 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2012 | 540 | 0.020 |
Why?
|
Torsion, Mechanical | 1 | 2009 | 7 | 0.020 |
Why?
|
Suture Techniques | 1 | 1991 | 130 | 0.020 |
Why?
|
Contraindications | 1 | 2009 | 85 | 0.020 |
Why?
|
Hospitals, Veterans | 1 | 2011 | 245 | 0.020 |
Why?
|
Graft Survival | 1 | 2012 | 481 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2011 | 241 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 293 | 0.020 |
Why?
|
Medication Errors | 1 | 2009 | 89 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2010 | 151 | 0.020 |
Why?
|
Inpatients | 1 | 2012 | 380 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2019 | 5089 | 0.020 |
Why?
|
Drug Utilization | 1 | 2009 | 166 | 0.020 |
Why?
|
Calibration | 1 | 2009 | 129 | 0.020 |
Why?
|
Europe | 1 | 2009 | 352 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2007 | 39 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 374 | 0.020 |
Why?
|
Regression Analysis | 1 | 2009 | 961 | 0.020 |
Why?
|
Veins | 1 | 2007 | 57 | 0.020 |
Why?
|
Wound Healing | 1 | 2009 | 263 | 0.020 |
Why?
|
Pain Measurement | 1 | 2009 | 450 | 0.020 |
Why?
|
Biomechanical Phenomena | 1 | 2009 | 678 | 0.020 |
Why?
|
Life Tables | 1 | 2006 | 17 | 0.020 |
Why?
|
Drug Implants | 1 | 2006 | 71 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1986 | 129 | 0.020 |
Why?
|
Program Evaluation | 1 | 2010 | 839 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2007 | 414 | 0.020 |
Why?
|
Pattern Recognition, Automated | 1 | 2006 | 70 | 0.020 |
Why?
|
Artifacts | 1 | 2006 | 123 | 0.020 |
Why?
|
Aorta | 1 | 2007 | 354 | 0.020 |
Why?
|
Acute Disease | 1 | 2007 | 917 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2006 | 146 | 0.010 |
Why?
|
Probability | 1 | 2005 | 297 | 0.010 |
Why?
|
Streptokinase | 2 | 1998 | 11 | 0.010 |
Why?
|
Critical Illness | 1 | 2009 | 646 | 0.010 |
Why?
|
Whole-Body Irradiation | 1 | 2004 | 72 | 0.010 |
Why?
|
Diabetes Insipidus | 1 | 1983 | 7 | 0.010 |
Why?
|
Pain | 1 | 2009 | 713 | 0.010 |
Why?
|
Sound | 1 | 1983 | 67 | 0.010 |
Why?
|
Technology | 1 | 1983 | 77 | 0.010 |
Why?
|
Heart Function Tests | 1 | 2003 | 59 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2014 | 3086 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 2003 | 90 | 0.010 |
Why?
|
Aging | 1 | 2012 | 1641 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2004 | 187 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2006 | 686 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2002 | 440 | 0.010 |
Why?
|
Exercise | 1 | 1989 | 1611 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2003 | 1665 | 0.010 |
Why?
|
Ultrasonography | 1 | 2001 | 671 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1997 | 72 | 0.010 |
Why?
|
Hospitalization | 1 | 2006 | 1761 | 0.010 |
Why?
|
Chronic Disease | 1 | 2003 | 1602 | 0.010 |
Why?
|
Safety | 1 | 1998 | 298 | 0.010 |
Why?
|
Traction | 1 | 1994 | 15 | 0.010 |
Why?
|
Subclavian Vein | 1 | 1994 | 19 | 0.010 |
Why?
|
Femoral Vein | 1 | 1994 | 28 | 0.010 |
Why?
|
Staphylococcus epidermidis | 1 | 1994 | 71 | 0.010 |
Why?
|
Steroids | 1 | 1994 | 147 | 0.010 |
Why?
|
Adolescent | 3 | 1998 | 17955 | 0.010 |
Why?
|
Pilot Projects | 1 | 1997 | 1374 | 0.010 |
Why?
|
Cytarabine | 1 | 1993 | 52 | 0.010 |
Why?
|
Vincristine | 1 | 1993 | 96 | 0.010 |
Why?
|
Mechlorethamine | 1 | 1993 | 64 | 0.010 |
Why?
|
Drug Resistance | 1 | 1993 | 162 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1993 | 180 | 0.010 |
Why?
|
Doxorubicin | 1 | 1993 | 290 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 850 | 0.010 |
Why?
|
Atrioventricular Node | 1 | 1990 | 13 | 0.010 |
Why?
|
Body Constitution | 1 | 1990 | 47 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 1994 | 338 | 0.010 |
Why?
|
Dizziness | 1 | 1990 | 70 | 0.010 |
Why?
|
Respiration | 1 | 1990 | 180 | 0.010 |
Why?
|
Syndrome | 1 | 1990 | 339 | 0.010 |
Why?
|
Dyspnea | 1 | 1990 | 223 | 0.010 |
Why?
|
Cardiac Complexes, Premature | 1 | 1988 | 2 | 0.010 |
Why?
|
Refractory Period, Electrophysiological | 1 | 1988 | 5 | 0.010 |
Why?
|
Fatigue | 1 | 1990 | 295 | 0.010 |
Why?
|
Protein Binding | 1 | 1993 | 1919 | 0.000 |
Why?
|
Tromethamine | 1 | 1986 | 2 | 0.000 |
Why?
|
Potassium Chloride | 1 | 1986 | 35 | 0.000 |
Why?
|
Citrates | 1 | 1986 | 44 | 0.000 |
Why?
|
Heart Arrest, Induced | 1 | 1986 | 30 | 0.000 |
Why?
|
Citric Acid | 1 | 1986 | 30 | 0.000 |
Why?
|
Glutamates | 1 | 1986 | 59 | 0.000 |
Why?
|
Aspartic Acid | 1 | 1986 | 79 | 0.000 |
Why?
|
Phosphates | 1 | 1986 | 160 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1986 | 213 | 0.000 |
Why?
|
Anxiety | 1 | 1990 | 853 | 0.000 |
Why?
|
Diuresis | 1 | 1983 | 8 | 0.000 |
Why?
|
Arginine Vasopressin | 1 | 1983 | 46 | 0.000 |
Why?
|
Vasopressins | 1 | 1983 | 57 | 0.000 |
Why?
|
Heart | 1 | 1986 | 612 | 0.000 |
Why?
|
Glucose | 1 | 1986 | 904 | 0.000 |
Why?
|
Surveys and Questionnaires | 1 | 1990 | 4671 | 0.000 |
Why?
|